Efficacy and safety of a double‐coated paclitaxel‐eluting coronary stent: The EUCATAX trial

Abstract

The study shows that patients treated with PES with dual coating technology had significantly lower incidence of TVF and MACE than those treated with BMS design; however, longer follow-up should be necessary to assess true advantages of this technology compared with the previous one.